BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28286801)

  • 21. Autophagy Dysfunction in Alzheimer's Disease: Mechanistic Insights and New Therapeutic Opportunities.
    Di Meco A; Curtis ME; Lauretti E; Praticò D
    Biol Psychiatry; 2020 May; 87(9):797-807. PubMed ID: 31262433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
    Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
    Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting Autophagy for the Treatment of Alzheimer's Disease: Challenges and Opportunities.
    Liu J; Li L
    Front Mol Neurosci; 2019; 12():203. PubMed ID: 31507373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer's disease?
    Cai Z; Zhao B; Li K; Zhang L; Li C; Quazi SH; Tan Y
    J Neurosci Res; 2012 Jun; 90(6):1105-18. PubMed ID: 22344941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Ubiquitin System in Alzheimer's Disease.
    Harris LD; Jasem S; Licchesi JDF
    Adv Exp Med Biol; 2020; 1233():195-221. PubMed ID: 32274758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macroautophagy--a novel Beta-amyloid peptide-generating pathway activated in Alzheimer's disease.
    Yu WH; Cuervo AM; Kumar A; Peterhoff CM; Schmidt SD; Lee JH; Mohan PS; Mercken M; Farmery MR; Tjernberg LO; Jiang Y; Duff K; Uchiyama Y; Näslund J; Mathews PM; Cataldo AM; Nixon RA
    J Cell Biol; 2005 Oct; 171(1):87-98. PubMed ID: 16203860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selenium-enriched yeast inhibited β-amyloid production and modulated autophagy in a triple transgenic mouse model of Alzheimer's disease.
    Song GL; Chen C; Wu QY; Zhang ZH; Zheng R; Chen Y; Jia SZ; Ni JZ
    Metallomics; 2018 Aug; 10(8):1107-1115. PubMed ID: 30043821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selenomethionine Attenuates the Amyloid-β Level by Both Inhibiting Amyloid-β Production and Modulating Autophagy in Neuron-2a/AβPPswe Cells.
    Zhang ZH; Wu QY; Chen C; Zheng R; Chen Y; Liu Q; Ni JZ; Song GL
    J Alzheimers Dis; 2017; 59(2):591-602. PubMed ID: 28671121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autophagic flux control in neurodegeneration: Progress and precision targeting-Where do we stand?
    Lumkwana D; du Toit A; Kinnear C; Loos B
    Prog Neurobiol; 2017 Jun; 153():64-85. PubMed ID: 28385648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autophagy modulation for Alzheimer's disease therapy.
    Zhu XC; Yu JT; Jiang T; Tan L
    Mol Neurobiol; 2013 Dec; 48(3):702-14. PubMed ID: 23625314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloid β-Derived Diffusible Ligands (ADDLs) Induce Abnormal Autophagy Associated with Aβ Aggregation Degree.
    Wen J; Fang F; Guo SH; Zhang Y; Peng XL; Sun WM; Wei XR; He JS; Hung T
    J Mol Neurosci; 2018 Feb; 64(2):162-174. PubMed ID: 29260451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex Differences in Autophagy Contribute to Female Vulnerability in Alzheimer's Disease.
    Congdon EE
    Front Neurosci; 2018; 12():372. PubMed ID: 29988365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Berberine mitigates cognitive decline in an Alzheimer's Disease Mouse Model by targeting both tau hyperphosphorylation and autophagic clearance.
    Chen Y; Chen Y; Liang Y; Chen H; Ji X; Huang M
    Biomed Pharmacother; 2020 Jan; 121():109670. PubMed ID: 31810131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autophagy dysfunction in Alzheimer's disease.
    Li L; Zhang X; Le W
    Neurodegener Dis; 2010; 7(4):265-71. PubMed ID: 20551691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial control of autophagic lysosomal pathway in Alzheimer's disease.
    Cardoso SM; Pereira CF; Moreira PI; Arduino DM; Esteves AR; Oliveira CR
    Exp Neurol; 2010 Jun; 223(2):294-8. PubMed ID: 19559703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autophagic degradation of tau in primary neurons and its enhancement by trehalose.
    Krüger U; Wang Y; Kumar S; Mandelkow EM
    Neurobiol Aging; 2012 Oct; 33(10):2291-305. PubMed ID: 22169203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's disease and the autophagic-lysosomal system.
    Chung KM; Hernández N; Sproul AA; Yu WH
    Neurosci Lett; 2019 Apr; 697():49-58. PubMed ID: 29758300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition.
    Liu CC; Hu J; Zhao N; Wang J; Wang N; Cirrito JR; Kanekiyo T; Holtzman DM; Bu G
    J Neurosci; 2017 Apr; 37(15):4023-4031. PubMed ID: 28275161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease.
    Volloch V; Olsen BR; Rits S
    Ann Integr Mol Med; 2019; 1(1):61-74. PubMed ID: 31858090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.